Article Per Year (5 Year)
p-Index From 2020 - 2025
1.686
P-Index
This Author published in this journals
All Journal International Journal of Integrated Health Sciences Majalah Kedokteran Bandung Althea Medical Journal Indonesian Journal of Rheumatology Majalah Kedokteran Neurosains Medica Hospitalia Indonesian Journal of Clinical Pathology and Medical Laboratory (IJCPML) The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Anna Tjandrawati
Department Of Clinical Pathology, Faculty Of Medicine, Padjadjaran University/Dr. Hasan Hasan Sadikin Hospital, Bandung
Biochemistry, Genetics & Molecular Biology Dentistry Health Professions Medicine & Pharmacology Neuroscience Nursing Public Health

Published : 23 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 23 Documents
Search

 1   2   3 
PENINGKATAN KADAR BILIRUBIN TOTAL SERUM DAN KAITANNYA DENGAN DERAJAT KLINIS PASIEN COVID-19: Elevation of Total Bilirubin Serum and Its Correlation with Clinical State of Covid-19 Patient Rostini, Tiene; Kurnia Pramono, Laila; Tjandrawati, Anna; Harahap, Raja Iqbal Mulya
Medica Hospitalia : Journal of Clinical Medicine Vol. 9 No. 2 (2022): Med Hosp
Publisher : RSUP Dr. Kariadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (273.579 KB) | DOI: 10.36408/mhjcm.v9i2.697

Abstract

Latar belakang : Reseptor utama SARS-CoV-2, yaitu Angiotensin Converting Enzyme-2 (ACE-2) diekspresikan secara luas pada tubuh manusia. Derajat klinis infeksi Coronavirus Disease 2019 (COVID-19) bervariasi, dan diklasifikasikan menjadi asimtomatik, sakit ringan, sakit sedang, sakit berat, dan kritis. Peningkatan kadar bilirubin total serum sering dihubungkan dengan derajat klinis penyakit serta mortalitas COVID-19. Penelitian ini bertujuan untuk mengetahui peningkatan kadar bilirubin total serum dan hubungannya dengan derajat klinis infeksi COVID-19 Metode : Desain penelitian adalah cross sectional dengan pengambilan data secara simple random sampling. Data yang dikumpulkan sebanyak 73 sampel yang berasal dari RSUP Dr. Hasan Sadikin dalam periode Mei–Desember 2020. Data bilirubin total dan derajat klinis infeksi COVID-19 dianalisis menggunakan Uji Mann-Whitney dan Uji Spearman untuk mendapatkan hubungan antara kedua variabel. Hasil : Hasil penelitian ini menunjukkan laki-laki lebih banyak dari perempuan, dengan dominasi subjek berusia 46–65 tahun, yaitu sebanyak 47,9% dari keseluruhan sampel. Median kadar bilirubin total serum pada infeksi COVID-19 derajat klinis berat-kritis lebih tinggi dibandingkan derajat klinis sedang (0,8 mg/dl vs 0,4 mg/dl), dengan koefisien r sebesar 0,463 (p<0,05). Simpulan : Peningkatan kadar bilirubin total serum berhubungan dengan derajat klinis infeksi COVID-19 di RSUP Dr. Hasan Sadikin Bandung. Penelitian lebih lanjut dapat dilakukan secara kohort prospektif yang mengukur kadar bilirubin total serum secara serial dan menilai outcome subjek penelitian.
Interleukin-6 Level and Neutrophil-Lymphocytes Ratio and Severity of Coronavirus Disease 19 Latifah, Armina; Parwati, Ida; Tjandrawati, Anna; Suraya, Nida
Majalah Kedokteran Bandung Vol 56, No 1 (2024)
Publisher : Faculty of Medicine, Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.15395/mkb.v56.3039

Abstract

Interleukin-6 (IL-6) is a proinflammatory cytokine that plays an important role in hyperinflammation and cytokine storm in Coronavirus Disease 19 (COVID-19) patients. The neutrophil-lymphocyte ratio (NRL) describes the innate and adaptive immune responses. Elevated IL-6 and NLR levels usually indicate a severe clinical condition in COVID-19 patients. Aim of this study was to determine the correlation of IL-6 and NLR with the severity of illness in COVID-19 hospitalized patients. This was a descriptive correlative observational study with a cross-sectional design using secondary data from COVID-19 patients treated in Dr. Hasan Sadikin General Hospital, Bandung, Indonesia, from November 2020 to October 2021. There were 225 subjects who were classified by the severity and analyzed for IL-6 levels and NLR. Median levels of IL-6 at moderate, severe, and critical levels were 4.1 pg/mL, 20.4 pg/mL, and 38.8 pg/mL, respectively. The median NLR at moderate, severe, and critical grades were respectively 4.41, 9.65, and 17.79. The correlation between IL-6, NLR, and severity was 0.441 (p<0.001) and 0.408 (p<0.001). Meanwhile, the correlation between IL-6 levels and NLR in COVID-19 was 0.230 (p<0.001). Thus, IL-6 and NRL levels have a moderate positive correlation with the severity of COVID-19, while IL-6 and NRL have a weak correlation because IL-6 is not the only factor that affects the NRL.
Correlation of Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) with Liver Transient Elastography Results: An Evaluating Liver Fibrosis in Chronic Hepatitis B Patients Haryono, Haryono; Bestari, Muhammad Begawan; Agustanti, Nenny; Girawan, Dolvy; Wahyudi, Yudi; Abdurachman, Siti Aminah; Tjandrawati, Anna
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy Vol 24, No 1 (2023): VOLUME 24, NUMBER 1, April, 2023
Publisher : The Indonesian Society for Digestive Endoscopy

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24871/241202312-22

Abstract

Background: Transient elastography (TE) is widely recognized as a reliable surrogate marker for grading the severity of liver fibrosis in chronic hepatitis B (CHB) patients. Mac-2 binding protein of glycosylation isomer (M2BPGi) is a novel non-invasive serum biomarker for liver fibrosis staging in various liver diseases, including CHB. This study aimed to evaluate the correlation of M2BPGi and liver stiffness (LS), as measured through TE, in predicting the degree of liver fibrosis in CHB patients.Methods: A cross-sectional study was conducted at Dr. Hasan Sadikin General Hospital, Bandung, between September 2021 and January 2022. The study included patients diagnosed with chronic hepatitis B (CHB) based on clinical and biochemical assessments. All subjects underwent TE examination using Fibroscan®, and the M2BPGi levels were determined with an automated immunoassay analyzer HISCL-800, Sysmex, Japan. Statistical analysis was conducted using the Spearman rank correlation method, with a significance value of p0.05.Results: A total of 119 patients with chronic hepatitis B (CHB) were consecutively recruited (Male:Female = 66:53; median age: 43 years). The median M2BPGi level was 1.04 COI (range: 0.74–1.59), while the median liver stiffness (LS) was 7.3 kPa (range: 5.6–12.5). A moderate and statistically significant correlation was observed between M2BPGi and LS (r = 0.525; p 0.001). Median M2BPGi values by fibrosis stage were 0.89 COI for F0–F1, 0.88 for F2, 1.61 for F3, and 2.24 for F4 (p 0.001).Conclusion: This study revealed a moderate positive correlation between serum M2BPGi level and LS in CHB patients.
Co-Authors Bethy S. Hernowo Chakrawati Hayuningsih Coriejati Rita Dewi Kartika T Dewi Kartika Turbawaty Dolvy Girawan Efriyani, Yuhpita Indah Elsa Yulius Emmy Hermiyanti Pranggono Erna Jupri Hartanto Bayuaji Haryono Haryono Ida Parwati Ivana Dewi Ivana Dewi Juan Achmad Yudistira Kurnia Pramono, Laila Laniyati Hamijoyo, Laniyati Latifah, Armina Leni Lismayanti Leni Lismayanti Lidya Chaidir Linda Choerunnisa Maman Abdurahman Maria Enrica Mike Rezeki Muhammad Begawan Bestari Nadjwa Zamalek Dalimoenthe Nadjwa Zamalek Dalimoenthe Nenny Agustanti Nenny Gustiani Nida Suraya Nida Suraya Nida Suraya Nina Tristina Primal Sudjana Putri Vidyaniati Rachmat Gunadi Wachjudi Rachmat Gunadi Wachjudi Raja Iqbal Mulya Harahap Rizki Dumpatna Siti Aminah Abdurachman Stefanie Yuliana Usman Sumartini Dewi Sylvia Rachmayati Tiene Rostini, Tiene Toha Sapari Usman, Stefanie Yuliana Verina Logito Verina Logito Winda Agnestia Maranna Saragih Yudi Wahyudi Yudistira, Juan Achmad